β-lactam cephalosporin antibiotic cefepime has been uncovered to deplete PD-L1 and promote tumor DNA damage and increase sensitivity of DNA-damaging compounds in multiple tumor cell lines, such as bladder cancer, melanoma, GBM (glioblastoma multiforme) and ovarian cancer (135). This evidence concerns the gene CD274 and urinary bladder carcinoma.